Biotech

All Articles

Enanta's RSV antiviral crushes popular lots in challenge research

.Enanta Pharmaceuticals has connected its respiratory system syncytial virus (RSV) antiviral to sign...

Biogen containers SAGE-324 collaboration after essential shake stop working

.Biogen has actually carried out the final ceremonies to its own cooperation along with Sage Therape...

AbbVie Parkinson's drug coming from $8.7 B Cerevel acquistion ratings

.On the exact same time that some Parkinson's health condition medicines are actually being actually...

Arch shuts $3B-plus fund to cultivate biopharma upstarts

.On the heels of a $3 billion fund from Bain Funding Lifestyle Sciences, Arch Endeavor Partners is c...

Orion to use Aitia's 'electronic twins' to locate new cancer cells drugs

.Finnish biotech Orion has actually spied possible in Aitia's "electronic twin" technology to cultiv...

Windtree's shock med brings up blood pressure in most up-to-date phase 2 gain

.While Windtree Therapies has struggled to increase the economic origins required to survive, a stag...

2 cancer biotechs merge, creating global impact

.OncoC4 is taking AcroImmune-- and its own internal medical manufacturing functionalities-- under it...

Amgen files first phase 3 gain for $400M eczema drug

.Amgen has shared (PDF) the initial stage 3 information on its $400 million eczema drug, linking the...

Biogen, UCB document phase 3 lupus win after failing earlier test

.Biogen and UCB's bank on developing right into period 3 astride an unsuccessful study tries to have...

Aptadir really hopes brand new RNA preventions may turn around tricky cancers

.Italian biotech Aptadir Rehabs has released with the guarantee that its own pipe of preclinical RNA...